Pablo Prieto-Matos Selected Research

Toll-Like Receptor 3

1/2023

Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pablo Prieto-Matos Research Topics

Disease

2	Homozygous Familial Hypercholesterolemia 01/2018 - 07/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2018
2	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2018 - 01/2018
1	Muscle Weakness 10/2023
1	Intellectual Disability (Idiocy) 10/2023
1	Movement Disorders (Movement Disorder) 10/2023
1	Leukemia 01/2023
1	Infections 01/2022
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2018
1	Brachydactyly 01/2018
1	Kimberley Type Spondyloepiphyseal Dysplasia 01/2018
1	Aggrecan Type Spondyloepimetaphyseal Dysplasia 01/2018
1	Osteochondritis Dissecans 01/2018
1	Rare Diseases (Rare Disease) 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2016
1	Atherosclerotic Plaque (Atheroma) 07/2016
1	Atherosclerosis 07/2016
1	Aortic Valve Stenosis (Aortic Stenosis) 07/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2016

Drug/Important Bio-Agent (IBA)

2	oxidized low density lipoproteinIBA 01/2018 - 07/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2023
1	Toll-Like Receptor 3IBA 01/2023
1	ruxolitinibIBA 01/2022
1	Growth Hormone (Somatotropin)IBA 12/2018
1	LipidsIBA 01/2018
1	LDL CholesterolIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Aggrecans (Aggrecan)IBA 01/2018
1	CholesterolIBA 07/2016

Therapy/Procedure

1	Therapeutics 07/2016